Pharma Marketing Network

SEPTEMBER 6, 2023

“Artificial Intelligence” (AI) is certainly experiencing the shiny object spotlight in 2023. This summer, we started a research series on Current and Future AI Trends in Healthcare, where we surveyed over 150 physicians, and conducted both qualitative and quantitative research with pharma industry members from 20 different companies.

Healthcare 52

Healthcare Healthcare Physicians Ethics 52

The Marketing Advantage

MAY 8, 2023

May 9, 2023 Since the Orphan Drug Act was passed in 1983, the number of products being researched and approved for rare and orphan diseases has increased dramatically, offering hope and life-saving treatments for the millions of patients affected by these often under-served conditions.

Sales 52

Sales Physicians Consulting Education 52

PM360

AUGUST 9, 2022

How can we help ensure patients continue to take their medications as prescribed? The reasons why a patient may not take their medication are plentiful, and as a result so are the solutions now available to attempt to solve this issue. But it is not a simple answer. Furthermore, it is estimated to reach $6.5

Prescription 105

Prescription Medical Side effects Patients 105

Pharmaceutical Technology

APRIL 13, 2023

Many of the GLP-1RAs are used off-label and are mainly indicated for patients with type 2 diabetes (T2D). Improved awareness of the risks of obesity and disease progression may also help improve access to resources and treatment available for patients with obesity.

Marketing 52

Marketing Side effects Physicians Management 52

PM360

JULY 13, 2023

Here are twelve of the best examples of programs, strategies, solutions, technology, and more that companies have developed or are using to keep patients on their prescribed therapies. But outdated manual processes are complex and leave many patients out. But outdated manual processes are complex and leave many patients out.

Education 89

Education Medical Media Patients 89

PM360

AUGUST 24, 2023

biosimilars market is evolving rapidly and pharma marketing programs need to evolve as well to better meet physician needs. healthcare system but we haven’t seen widespread acceptance by doctors and patients. But how can biosimilar brands most effectively support providers and patients throughout the care journey?

Marketing 97

Marketing Physicians Electronics Side effects 97

pharmaphorum

SEPTEMBER 16, 2022

UK-based George Medicines is running a phase 3 trial of GMRx2 – a low-dose formulation of established blood pressure drugs telmisartan, amlodipine, and indapamide – involving 1,500 patients across seven countries. By 2030, it is projected that over 215 million Africans will have hypertension.

Side effects 52

Side effects Medicine Healthcare Provider Patients 52

Medgadget

FEBRUARY 17, 2023

All of these systems operate under the “master-slave” concept, which involves a surgeon sitting behind a console, away from the patient, who manipulates the mechanical arms of the robot via some kind of joystick-like device. are still done in an open fashion.

Physicians 80

Physicians Engineering Side effects Leads 80

Nixon Gwilt Law

NOVEMBER 5, 2021

On November 2, 2021, the Centers for Medicare and Medicaid Services (“CMS”) finalized the Medicare Physician Fee Schedule for Calendar Year 2022 (the “Final 2022 MPFS” or the “Final Rule”). CMS will evaluate such requests and propose any additions in the 2023 Proposed Medicare Physician Fee Schedule.

Physicians 52

Physicians Professional Services Side effects Medical 52

European Pharmaceutical Review

DECEMBER 27, 2023

Due to shipping and manufacturing requirements, the time from a patient being included in the CAR T programme to receiving therapy can be several weeks. As a result, many patients waiting for the CAR T cells to be infused will need additional therapy (bridging therapy) against the malignance.

Manufacturing 86

Manufacturing Food and Drug Administration Patients Pharma 86